Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.
Therapies based on compassion are more cost-effective and associated with a better quality of life than are those using relaxation techniques ... Read more
Adding medical cannabis to standard pain relief therapy leads to clinical improvements in a significant proportion of patients with fibromyalgia, particularly ... Read more
People with fibromyalgia have poor sleep quality and experience more sleep disturbances than people without the disorder, according to data from ... Read more
Regular, moderate to intense physical activity has long‐term benefits as far as fitness, pain relief, disease burden, and quality of life ... Read more
Tonix Pharmaceuticals has finished the essential fed-fasting and dose proportionality tests of its TNX-102 SL investigational therapy in healthy volunteers. The ... Read more
Patients with chronic fatigue syndrome and fibromyalgia have higher levels of high-sensitivity C-reactive protein (hsCRP) — a marker of inflammation — ... Read more
Following an agreement with Pfizer, Axsome Therapeutics now has exclusive rights to develop and commercialize AXS-14 (esreboxetine) — a drug candidate ... Read more
